Jiang, Dan
Wang, Kuan
Funding for this research was provided by:
Risk factors related to prognosis and survival prediction model for gastric cancer patients with peritoneal metastasis treated with hyperthermic intraperitoneal chemotherapy (NO.0401-22012180039)
Article History
Received: 22 April 2026
Accepted: 4 September 2026
First Online: 8 September 2026
Declarations
Ethics approval and consent to participate: All human tissue sample collection procedures were reviewed and approved by the Ethics Committee of Harbin Medical University Cancer Hospital (approval number: YD2024-19). All animal experimental operations were approved by the Animal Ethics Committee of Harbin Medical University Cancer Hospital. No clinical trial registration number was applicable to this study. Written informed consent was acquired from every adult patient enrolled in this research before collecting pancreatic tumor and matched adjacent normal tissue samples. Individuals younger than 18 years old were not recruited into this study.
Consent for publication: All participating patients provided written informed consent to permit the publication of de-identified clinical data, experimental detection results and related research figures generated from their tissue samples.
Competing interests: The authors declare no competing interests.